Research - Nashville, Tennessee, United States
RegenConBio, LLC provides direct, professional services to its two current subsidiary companies, Regenerative Outcomes, LLC and Galaxy AI Innovations, LLC.As well as employing and contracting with a world-class team that positions it to leverage the incredible technological and clinical advancements being made around the globe in the field, RegenConBio serves as a centralized support structure for Regenerative Outcomes and Galaxy AI Innovations, allowing them to operate with minimum overhead and maximum efficiency and profitability, as well as aligning our business model in preparation for franchise opportunities overseas.The Company's Mission is to deliver breakthrough, life-saving therapies and technologies, with focus in Regenerative Medicine and Gene Therapy. Harnessing the power of AI and advanced technology we will also deliver digital therapeutics addressing the Opioid crisis, and AI quantum-computer designed small molecules to improve the lives of more patients suffering from cancer & rare diseases.